These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6312638)

  • 1. Mutagenicity and in vivo disposition of biliary metabolites of benzo(a)pyrene.
    Chipman JK; Millburn P; Brooks TM
    Toxicol Lett; 1983 Jul; 17(3-4):233-40. PubMed ID: 6312638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity of benzo(a)pyrene-3-O-glucuronide, a biliary metabolite of benzo(a)pyrene.
    Chipman JK; Millburn P; Brooks TM
    Toxicol Lett; 1983 Jul; 17(3-4):361-2. PubMed ID: 6312639
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between benzo(a)pyrene-induced DNA base modification and frequency of reverse mutations in mutant strains of Salmonella typhimurium.
    Fahl WE; Scarpelli DG; Gill K
    Cancer Res; 1981 Sep; 41(9 Pt 1):3400-6. PubMed ID: 6266655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
    Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenic activity of biliary metabolites of 6-hydroxymethylbenzo[a]pyrene.
    Hughes MF; Kadry AR; Gairola CG; Flesher JW
    Mutat Res; 1986 Apr; 173(4):251-6. PubMed ID: 3513004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of uptake and biliary excretion of benzo(alpha)pyrene and mutagenic metabolites in isolated perfused rat liver.
    Forti GC; Trieff NM
    Teratog Carcinog Mutagen; 1980; 1(3):269-82. PubMed ID: 6119817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excretion of 3-hydroxy-benzo(a)pyrene and mutagenicity in rat urine after exposure to benzo(a)pyrene.
    Jongeneelen FJ; Leijdekkers CM; Bos RP; Theuws JL; Henderson PT
    J Appl Toxicol; 1985 Oct; 5(5):277-82. PubMed ID: 3902943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of mutagenic metabolites of benzo[a]pyrene from the perfused rat liver after inhibition of glucuronidation and sulfation by salicylamide.
    Bock KW; Bock-Hennig BS; Lilienblum W; Volp RF
    Chem Biol Interact; 1981 Aug; 36(2):167-77. PubMed ID: 6268312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and biological activity of benzo[a]pyrene-7,8-dione. A genotoxic metabolite generated by dihydrodiol dehydrogenase.
    Flowers L; Bleczinski WF; Burczynski ME; Harvey RG; Penning TM
    Biochemistry; 1996 Oct; 35(42):13664-72. PubMed ID: 8885846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary excretion, systemic availability and reactivity of metabolites following intraportal infusion of [3H]benzo[a]pyrene in the rat.
    Chipman JK; Frost GS; Hirom PC; Millburn P
    Carcinogenesis; 1981; 2(8):741-5. PubMed ID: 6269773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-mediated mutagenicity experiments with benzo[a]pyrene and two of its metabolites.
    Glatt H; Bücker M; Platt KL; Oesch F
    Mutat Res; 1985 Jun; 156(3):163-9. PubMed ID: 3889634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat nasal tissue activation of benzo(a)pyrene and 2-aminoanthracene to mutagens in Salmonella typhimurium.
    Bond JA; Li AP
    Environ Mutagen; 1983; 5(3):311-8. PubMed ID: 6303770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and enterohepatic circulation of benzo(a)pyrene-4,5-epoxide in the rat.
    Elmhirst TR; Chipman JK; Ribeiro O; Hirom PC; Millburn P
    Xenobiotica; 1985 Nov; 15(11):899-906. PubMed ID: 4082630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between mutation spectra and stable and unstable DNA adduct profiles in Salmonella for benzo[a]pyrene and dibenzo[a,l]pyrene.
    DeMarini DM; Hanley NM; Warren SH; Adams LD; King LC
    Mutat Res; 2011 Sep; 714(1-2):17-25. PubMed ID: 21689667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of benzo(a)pyrenyl-1-sulfate in the Ames test.
    Irwin SE; Kwei GY; Blackburn GR; Thurman R; Kauffman FC
    Environ Mol Mutagen; 1992; 19(3):253-8. PubMed ID: 1572348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and excretion of benzo[a]pyrene in the rabbit.
    Chipman JK; Bhave NA; Hirom PC; Millburn P
    Xenobiotica; 1982 Jun; 12(6):397-404. PubMed ID: 6291260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell specific activation of benzo[a]pyrene by fibroblasts and hepatocytes.
    Jones CA; Santella RM; Huberman E; Selkirk JK; Grunberger D
    Carcinogenesis; 1983 Nov; 4(11):1351-7. PubMed ID: 6315253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat and human explant metabolism, binding studies, and DNA adduct analysis of benzo(a)pyrene and its 6-nitro derivative.
    Garner RC; Stanton CA; Martin CN; Harris CC; Grafstrom RC
    Cancer Res; 1985 Dec; 45(12 Pt 1):6225-31. PubMed ID: 4063973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.